Even after a strong year like 2025, your capital still needs to be employed. Leaving gains idle as cash is inefficient, while ...
Based on the topline results from the EPCORE® DLBCL-1 trial, AbbVie along with partner Genmab will engage global regulatory authorities to discuss next steps NORTH ...
HINGHAM INSTITUTION FOR SAVINGS (NASDAQ: HIFS), Hingham, Massachusetts announced earnings for the fourth quarter and the year ended December 31, 2025.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback